- Home
- China
- World
- Asia-Pacific
- Americas
- Europe
- Middle-East and Africa
- Politics
- Business
- Opinions
- Tech & Sci
- Culture
- Sports
- Travel
- Nature
- Picture
- Video
- Live
- TV
- Radio
- Specials
- Learn Chinese
North America
20:04, 25-Jan-2022
Pfizer, BioNTech launch trial for Omicron-targeted COVID-19 vaccine
Share
Copied
Pfizer and BioNTech said on Tuesday they started a clinical trial for the Omicron-specific COVID-19 vaccine.
The study will evaluate the safety, tolerability and the level of immune response of the vaccine, according to the news release.
